Diabetes Linked to Persistent Pain After Joint Replacement!

By /

persistent pain after joint replacement

Given the lack of predictive models to identify patients who are at risk for persistent pain after joint replacement, this study is a welcome start as it has identified a primary, though not surprising, risk factor: Diabetes.

Strong relationships have already been established between arthritis and high blood sugar. High glucose concentrations even below the diabetic level have been associated with tibial cartilage volume loss and bone lesions in women, and poor blood sugar control is known to contribute to the catabolic joint stew which breaks down joint bone and cartilage in arthritis in general. At a deeper level, a hormone called Osteocalcin which is a chemical messenger secreted only by the osteoblasts (bone stem cells) within your bones, has been demonstrated to be a crucial part of the blood sugar control system. A Columbia study back in 2010 established that your pancreas produces insulin, the insulin talks to your bone osteoblasts which in turn talk back through Osteocalcin, to help keep blood sugar in check.

This study set out to establish, or rule out, an association between persistent pain after joint replacement and disorders of glucose metabolism, metabolic syndrome and obesity. For the purpose of the study, persistent pain was defined as pain lasting 3 or more months in the operated joint. One hundred and ninety three Osteoarthritis patients, of which 74 were total hip, and 119 total knee, were surveyed 1-2 years after surgery. All patients’ blood sugar levels had been established and recorded prior to their surgery. After excluding participants for additional surgeries, 134 were actually studied. Various metrics were applied to account for age, sex and which joint operated.  The results were 37% of the patients had painful joints and 14% had persistent pain, knee patients being more affected than hip patients. Of the three conditions considered, only previously diagnosed Diabetes was strongly associated with persistent pain (5/19 with diabetes, only 13/115 without), concluding that Diabetes is a risk factor for persistent pain 1-2 years post surgery for primary total hip and knee replacement patients.

The upshot? Though this was the obvious first place to look given the established relationship between blood sugar and arthritis, the results were significant.  Optimistically, these findings will inspire additional research into identifying all the risk factors for post surgical persistent pain after joint replacement.  While at some point injectable biologics will replace most orthopedic surgeries and joint replacements will be reserved for cases in which all other options have failed, at present, hip and knee replacements continue to be done routinely. Hopefully, this type of research will give physicians the opportunity to work on the risk factors BEFORE surgery, rather than the patients dealing with the consequences after the fact!

Join us for a free Regenexx webinar.
Chris Centeno, MD is a specialist in regenerative medicine and the new field of Interventional Orthopedics. Centeno pioneered orthopedic stem cell procedures in 2005 and is responsible for a large amount of the published research on stem cell use for orthopedic applications. View Profile

If you have questions or comments about this blog post, please email us at [email protected]

NOTE: This blog post provides general information to help the reader better understand regenerative medicine, musculoskeletal health, and related subjects. All content provided in this blog, website, or any linked materials, including text, graphics, images, patient profiles, outcomes, and information, are not intended and should not be considered or used as a substitute for medical advice, diagnosis, or treatment. Please always consult with a professional and certified healthcare provider to discuss if a treatment is right for you.

Get Blog Updates by Email

We do not sell, or share your information to third party vendors.

By submitting the form you agree that you’ve read and consent to our Privacy Policy. We may use email, phone, or other electronic means to communicate information about Regenexx.

We will provide information to help you decide whether you want to schedule an evaluation with a Regenexx Physician.

Insurance typically covers evaluations and diagnostic testing (if recommended). Most insurance plans currently do not cover Regenexx Procedures.

Category: Latest News
Copyright © Regenexx 2021. All rights reserved.



9035 Wadsworth Pkwy #1000
Westminster, CO 80021


*DISCLAIMER: Like all medical procedures, Regenexx® Procedures have a success and failure rate. Patient reviews and testimonials on this site should not be interpreted as a statement on the effectiveness of our treatments for anyone else.

Providers listed on the Regenexx website are for informational purposes only and are not a recommendation from Regenexx for a specific provider or a guarantee of the outcome of any treatment you receive.